This company listing is no longer active
Clorox Management
Management criteria checks 2/4
Clorox's CEO is Linda Rendle, appointed in Sep 2020, has a tenure of 3.92 years. total yearly compensation is $11.65M, comprised of 10% salary and 90% bonuses, including company stock and options. directly owns 0.031% of the company’s shares, worth €5.03M. The average tenure of the management team and the board of directors is 3.9 years and 6.8 years respectively.
Key information
Linda Rendle
Chief executive officer
US$11.6m
Total compensation
CEO salary percentage | 10.0% |
CEO tenure | 3.9yrs |
CEO ownership | 0.03% |
Management average tenure | 3.9yrs |
Board average tenure | 6.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Jun 30 2024 | n/a | n/a | US$280m |
Mar 31 2024 | n/a | n/a | US$240m |
Dec 31 2023 | n/a | n/a | US$80m |
Sep 30 2023 | n/a | n/a | US$86m |
Jun 30 2023 | US$12m | US$1m | US$149m |
Mar 31 2023 | n/a | n/a | US$74m |
Dec 31 2022 | n/a | n/a | US$435m |
Sep 30 2022 | n/a | n/a | US$405m |
Jun 30 2022 | US$9m | US$1m | US$462m |
Mar 31 2022 | n/a | n/a | US$458m |
Dec 31 2021 | n/a | n/a | US$247m |
Sep 30 2021 | n/a | n/a | US$437m |
Jun 30 2021 | US$8m | US$1m | US$710m |
Mar 31 2021 | n/a | n/a | US$923m |
Dec 31 2020 | n/a | n/a | US$1b |
Sep 30 2020 | n/a | n/a | US$1b |
Jun 30 2020 | US$2m | US$524k | US$939m |
Mar 31 2020 | n/a | n/a | US$870m |
Dec 31 2019 | n/a | n/a | US$816m |
Sep 30 2019 | n/a | n/a | US$813m |
Jun 30 2019 | US$2m | US$436k | US$820m |
Mar 31 2019 | n/a | n/a | US$796m |
Dec 31 2018 | n/a | n/a | US$790m |
Sep 30 2018 | n/a | n/a | US$841m |
Jun 30 2018 | US$2m | US$436k | US$823m |
Compensation vs Market: Linda's total compensation ($USD11.65M) is above average for companies of similar size in the BG market ($USD4.45M).
Compensation vs Earnings: Linda's compensation has increased by more than 20% in the past year.
CEO
Linda Rendle (45 yo)
3.9yrs
Tenure
US$11,649,651
Compensation
Ms. Linda Rendle serves as Chief Executive Officer and Director of The Clorox Company since September 14 2020 & serves as January 1, 2024. Ms. Rendle served as President of The Clorox Company from May 4, 2...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Chairman | 3.9yrs | US$11.65m | 0.031% € 5.0m | |
Executive VP & CFO | 6.3yrs | US$4.43m | 0.030% € 4.9m | |
Executive VP & Chief Operating and Strategy Officer | 3.9yrs | US$4.85m | 0.029% € 4.8m | |
Executive VP and Chief People & Corporate Affairs Officer | 8.4yrs | US$3.36m | 0.014% € 2.3m | |
Executive VP and Executive Chief of Staff | 2.4yrs | US$3.56m | 0.0028% € 460.8k | |
VP, Chief Accounting Officer & Corporate Controller | 3.3yrs | no data | 0.0012% € 202.6k | |
Senior VP and Chief Information & Enterprise Data Officer | 4.2yrs | no data | no data | |
Vice President of Investor Relations | no data | no data | no data | |
Executive VP & Chief Legal Officer | 19.1yrs | no data | 0.0061% € 998.5k | |
Senior VP & Chief Marketing Officer | 2.4yrs | no data | no data | |
Chief Diversity Officer | 18.2yrs | no data | no data | |
Senior VP & Chief Product Supply Officer | 3.7yrs | no data | no data |
3.9yrs
Average Tenure
53yo
Average Age
Experienced Management: CXX's management team is considered experienced (3.9 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Chairman | 3.9yrs | US$11.65m | 0.031% € 5.0m | |
Independent Director | 9.1yrs | US$280.00k | 0.0010% € 171.6k | |
Independent Director | 8yrs | US$260.00k | 0.00048% € 78.4k | |
Independent Director | 9.1yrs | US$285.00k | 0.00036% € 58.8k | |
Independent Director | 3.8yrs | US$260.00k | 0.00072% € 117.7k | |
Independent Director | 7.9yrs | US$260.00k | 0.00029% € 47.4k | |
Independent Director | 11yrs | US$275.00k | no data | |
Lead Independent Director | 6yrs | US$435.00k | no data | |
Independent Director | 4.3yrs | US$260.00k | no data | |
Independent Director | 7.5yrs | US$260.00k | no data | |
Independent Director | 2.3yrs | US$260.00k | no data | |
Independent Director | 2.3yrs | US$260.00k | no data |
6.8yrs
Average Tenure
61.5yo
Average Age
Experienced Board: CXX's board of directors are considered experienced (6.8 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/08/08 23:56 |
End of Day Share Price | 2024/08/08 00:00 |
Earnings | 2024/06/30 |
Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
The Clorox Company is covered by 43 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
John Staszak | Argus Research Company |
Edward Lewis | Atlantic Equities LLP |
Ishan Majumdar | Baptista Research |